Effect of green coffee on miR-133a, miR-155 and inflammatory biomarkers in obese individuals

Naglaa F. Khedr,Enas S. Zahran,Abla M. Ebeid,Samuel T. Melek,Rehab H. Werida
DOI: https://doi.org/10.1186/s13098-024-01478-7
2024-10-31
Diabetology & Metabolic Syndrome
Abstract:Metabolic syndrome is a cluster of conditions that increases the risk of atherosclerotic cardiovascular diseases. The current study was a randomized, double blind, placebo-controlled study that aimed to determine the impact of green coffee (GC) in obese patients with metabolic syndrome through analysis of miRNA-155, miRNA-133a and the inflammatory biomarkers such as resistin, TNF-α, total sialic acid, homocysteine, high sensitivity C-reactive protein (hs-CRP), and the anti-inflammatory cytokine, adiponectin.
endocrinology & metabolism
What problem does this paper attempt to address?